How to buy Monash IVF Group shares | A$0.58

Monash IVF Group Limited is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.58 – a decrease of 0.85% over the previous week. Monash IVF Group has a trailing 12-month revenue of around $145.4 million.

How to buy shares in Monash IVF Group

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Monash IVF Group. Find the share by name or ticker symbol: MVF. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Monash IVF Group reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $0.58, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Monash IVF Group. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Monash IVF Group's share price?

Since the stock market crash in March caused by coronavirus, Monash IVF Group's share price has had significant negative movement.

Its last market close was $0.58, which is 42.57% down on its pre-crash value of $1.01 and 52.63% up on the lowest point reached during the March crash when the shares fell as low as $0.38.

If you had bought $1,000 worth of Monash IVF Group shares at the start of February 2020, those shares would have been worth $441.63 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $588.83.

Monash IVF Group share price

Use our graph to track the performance of MVF stocks over time.

Monash IVF Group shares at a glance

• Key figures

Information last updated 2020-09-20.

Latest market close	AUDA$0.58
52-week range	AUDA$0.38 - AUDA$1.115
50-day moving average	AUDA$0.5874
200-day moving average	AUDA$0.5832
Target price	AUDA$1.31
PE ratio	13.5556
Dividend yield	AUDA$0.05 (7.81%)
Earnings per share (TTM)	AUDA$0.045

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Monash IVF Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Monash IVF Group Limited by TradingView

Monash IVF Group price performance over time

Historical closes compared with the last close of A$0.58

1 week (2020-09-14)	-0.85%
1 month (2020-08-21)	-7.94%
3 months (2020-06-19)	-0.85%
6 months (2020-03-20)	13.73%

1 year (2019-09-20)	-43.69%
2 years (2018-09-21)	-47.27%
3 years (2017-09-21)	-58.87%
5 years (2015-09-21)	-51.46%

Is Monash IVF Group under- or over-valued?

Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Monash IVF Group's P/E ratio

Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Monash IVF Group shares trade at around 14x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Monash IVF Group's EBITDA

Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $25.8 million (£0.0 million).

The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure a its profitability.

Monash IVF Group financials

Revenue TTM	$145.4 million
Operating margin TTM	15.39%
Gross profit TTM	$50.9 million
Return on assets TTM	4.38%
Return on equity TTM	5.53%
Profit margin	8.06%
Book value	0.641
Market capitalisation	$237.7 million

TTM: trailing 12 months

Monash IVF Group share dividends

Dividend payout ratio: 105.84% of net profits

Recently Monash IVF Group has paid out, on average, around 105.84% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.81% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 7.81% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.05 per share.

Monash IVF Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 4 March 2020 (the "ex-dividend date").

Monash IVF Group share price volatility

Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $0.38 up to $1.115. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.4898. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Monash IVF Group overview

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnosis and treatment of infertility, fertility research and treatment services, tertiary level prenatal diagnostic services, low intervention IVF services, and diagnostic ultrasound services. Monash IVF Group Limited was incorporated in 2014 and is based in Richmond, Australia.

Frequently asked questions

• What percentage of Monash IVF Group is owned by insiders or institutions?

  Currently 11.762% of Monash IVF Group shares are held by insiders and 31.887% by institutions.

• When does the fiscal year end for Monash IVF Group?

  Monash IVF Group's fiscal year ends in June.

• Where is Monash IVF Group based?

  Monash IVF Group's address is: Pelaco Building 1, Richmond, VIC, Australia, 3121

• What is Monash IVF Group's ISIN number?

  Monash IVF Group's international securities identification number is: AU000000MVF3